Clinical Trials Browser

Phase 1 × Mesothelioma × sargramostim × Clear all

NCT04040231 2025-05-13

Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma

Phase 1 Completed

GenitourinaryOther solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma, Wilms Tumor